Rh(III)-Catalyzed Redox-Neutral [4+2] Annulation for Direct Assembly of 3-Acyl Isoquinolin-1(2H)-ones as Potent Antitumor Agents

Chempluschem. 2020 Mar;85(3):405-410. doi: 10.1002/cplu.201900616. Epub 2019 Dec 11.

Abstract

By virtue of an efficient rhodium(III)-catalyzed redox-neutral C-H activation/ring-opening of a strained ring/[4+2] annulation cascade of N-methoxybenzamides with propargyl cycloalkanols, diverse 3-acyl isoquinolin-1(2H)-ones were directly obtained in good yields and with excellent functional group compatibility. Additionally, their antitumor activities against various human cancer cells including HepG2, A549, MCF-7 and SH-SY5Y were evaluated and the action mechanism of the selected compound was also investigated in vitro. The results revealed that these products possessed a potent efficacy, by inhibiting proliferation and inducing apoptosis in a time-dependent and dose-dependent manner, suggesting that such compounds can serve as promising candidates for anti lung cancer drug discovery.

Keywords: C−H functionalization; antitumor agents; cell apoptosis; isoquinolin-1(2H)-one; rhodium(III) catalysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Benzamides / chemistry
  • Catalysis
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cyclization
  • Drug Screening Assays, Antitumor
  • Humans
  • Isoquinolines / chemical synthesis*
  • Isoquinolines / pharmacology
  • Molecular Structure
  • Oxidation-Reduction
  • Rhodium / chemistry*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Isoquinolines
  • Rhodium
  • isoquinoline